Clindamycin hydrochloride and clindamycin phosphate: two drugs or one? A retrospective analysis of a spontaneous reporting system

  • Eur J Clin Pharmacol. 2017 Feb;73(2):251-253. doi: 10.1007/s00228-016-2161-7.
Haona Li  1 ,  Jianxiong Deng  2 ,  Zhihua Yue  3 ,  Yiexiang Zhang  2 ,  He Sun  4  5 ,  Xuequn Ren  6
Affiliations
  • 1. Huaihe Hospital of Henan University, Henan University, Kaifeng, 475004, Henan, People's Republic of China. [email protected].
  • 2. Adverse Drug Reaction Monitoring Centre of Guangdong Province, Guangzhou, People's Republic of China.
  • 3. Chinese Pharmacopoeia Commission, Beijing, People's Republic of China.
  • 4. Tasly Research and Development Institute, Tasly Pharmaceutical Co., Ltd., Tianjin, People's Republic of China.
  • 5. School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People's Republic of China.
  • 6. Huaihe Hospital of Henan University, Henan University, Kaifeng, 475004, Henan, People's Republic of China. [email protected].
PMID: 27853825 DOI: 10.1007/s00228-016-2161-7
Products